Delivery Order SPE2DB20D3101-SPE2DB25FRTA0
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,386.37 delivery order for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $10,418.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $14,014.80 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 19, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $76,017.62 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a ceiling value of $35,984.57. This firm fixed-price delivery order is expected to be completed by July 31, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting the vendor's demonstrated capability...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors, valued at $17,022.32. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The pharmaceutical product will be delivered to the DLA's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $35,870.18 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, executed on August 15, 2025, with an ultimate completion date of August 18, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,183.90 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a ceiling value of $9,335.21 and a completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a small-value transaction typical...
- The Defense Logistics Agency awarded a $25,796.39 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of August 20, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial pharmaceutical supply relationship with DLA, supporting federal...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTA0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Enbrel 50 mg/ml SureClick auto-injectors valued at $13,880.31. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for ultimate completion by August 20, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's Medical Supply Chain operations. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As one of the federal government's largest pharmaceutical distributors, AmerisourceBergen maintains a robust portfolio of federal medical contracts supporting military and veteran healthcare systems. The company's role as a prime vendor enables it to supply an extensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/19/25 |